published meta-analysis   sensitivity analysis   studies

placebo in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsZhang, 2020 (REV) 2.00 [0.67; 6.00] 2.00[0.67; 6.00]Zhang, 2020 (REV)10%56NAnot evaluable deathsdetailed resultsZhang, 2020 (REV) 2.00 [0.67; 6.00] 2.00[0.67; 6.00]Zhang, 2020 (REV)10%56NAnot evaluable deaths (time to event analysis only)detailed resultsZhang, 2020 (REV) 2.00 [0.67; 6.00] 2.00[0.67; 6.00]Zhang, 2020 (REV)10%56NAnot evaluable clinical deteriorationdetailed resultsZhang, 2020 (REV) 1.15 [0.31; 4.31] 1.15[0.31; 4.31]Zhang, 2020 (REV)10%56NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-05-17 12:21 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 650 - roots T: 650